Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...

All doses of Novo Nordisk’s blockbuster diabetes and obesity drugs were listed as available on the FDA shortage list as of ...

and highly personalised treatment alternative. With continued research and refinement, the DT intervention may become a ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...